Cargando…
Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69(+) T Regulatory Cells
T regulatory (Treg) cells have a key role in the pathogenesis of chronic inflammatory and autoimmune diseases. A CD4(+)CD69(+) T cell subset has been described that behaves as Treg lymphocytes, exerting an important immune suppressive effect. In this study, we analyzed the levels and function of CD4...
Autores principales: | Vitales-Noyola, Marlen, Oceguera-Maldonado, Brenda, Niño-Moreno, Perla, Baltazar-Benítez, Nubia, Baranda, Lourdes, Layseca-Espinosa, Esther, Abud-Mendoza, Carlos, González-Amaro, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606092/ https://www.ncbi.nlm.nih.gov/pubmed/29038617 http://dx.doi.org/10.1155/2017/2513829 |
Ejemplares similares
-
Analysis of Sodium Chloride Intake and Treg/Th17 Lymphocytes in Healthy Individuals and Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus
por: Vitales-Noyola, Marlen, et al.
Publicado: (2018) -
Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
por: Vitales-Noyola, Marlen, et al.
Publicado: (2022) -
Induction of Th17 Lymphocytes and Treg Cells by Monocyte-Derived Dendritic Cells in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Estrada-Capetillo, Lizbeth, et al.
Publicado: (2013) -
Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus
por: Guerra-de Blas, Paola del Carmen, et al.
Publicado: (2016) -
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
por: Vigna-Perez, Mónica, et al.
Publicado: (2006)